Human leukocyte antigen selected allogeneic mesenchymal stromal cell therapy in renal transplantation: The Neptune study, a phase I single‐center study

Mesenchymal stromal cells (MSC) hold promise as a novel immune‐modulatory therapy in organ transplantation. First clinical studies have used autologous MSCs; however, the use of allogeneic "off‐the‐shelf" MSCs is more sustainable for broad clinical implementation, although with the risk of...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Am J Transplant
Auteurs principaux: Dreyer, Geertje J., Groeneweg, Koen E., Heidt, Sebastiaan, Roelen, Dave L., van Pel, Melissa, Roelofs, Helene, Huurman, Volkert A. L., Bajema, Ingeborg M., Moes, Dirk Jan A. R., Fibbe, Willem E., Claas, Frans H. J., van Kooten, Cees, Rabelink, Rabelink J., de Fijter, Johan W., Reinders, Marlies E. J.
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2020
Sujets:
Brief Communications
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7586810/
https://ncbi.nlm.nih.gov/pubmed/32277568
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ajt.15910
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires